These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. PDAPP; YFP double transgenic mice: a tool to study amyloid-beta associated changes in axonal, dendritic, and synaptic structures. Brendza RP; O'Brien C; Simmons K; McKeel DW; Bales KR; Paul SM; Olney JW; Sanes JR; Holtzman DM J Comp Neurol; 2003 Feb; 456(4):375-83. PubMed ID: 12532409 [TBL] [Abstract][Full Text] [Related]
3. Use of YFP to study amyloid-beta associated neurite alterations in live brain slices. Brendza RP; Simmons K; Bales KR; Paul SM; Goldberg MP; Holtzman DM Neurobiol Aging; 2003 Dec; 24(8):1071-7. PubMed ID: 14643378 [TBL] [Abstract][Full Text] [Related]
4. Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer's disease. Sadleir KR; Kandalepas PC; Buggia-Prévot V; Nicholson DA; Thinakaran G; Vassar R Acta Neuropathol; 2016 Aug; 132(2):235-256. PubMed ID: 26993139 [TBL] [Abstract][Full Text] [Related]
5. Calsyntenin-3 C-terminal fragment accumulates in dystrophic neurites surrounding aβ plaques in tg2576 mouse and Alzheimer disease brains: its neurotoxic role in mediating dystrophic neurite formation. Uchida Y; Gomi F; Murayama S; Takahashi H Am J Pathol; 2013 May; 182(5):1718-26. PubMed ID: 23499467 [TBL] [Abstract][Full Text] [Related]
6. Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease. DeMattos RB; O'dell MA; Parsadanian M; Taylor JW; Harmony JA; Bales KR; Paul SM; Aronow BJ; Holtzman DM Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10843-8. PubMed ID: 12145324 [TBL] [Abstract][Full Text] [Related]
7. Oral nimodipine treatment has no effect on amyloid pathology or neuritic dystrophy in the 5XFAD mouse model of amyloidosis. Sadleir KR; Popovic J; Khatri A; Vassar R PLoS One; 2022; 17(2):e0263332. PubMed ID: 35108319 [TBL] [Abstract][Full Text] [Related]
8. Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease. Masliah E; Sisk A; Mallory M; Mucke L; Schenk D; Games D J Neurosci; 1996 Sep; 16(18):5795-811. PubMed ID: 8795633 [TBL] [Abstract][Full Text] [Related]
9. Effect of neocortical and hippocampal amyloid deposition upon galaninergic and cholinergic neurites in AβPPswe/PS1ΔE9 mice. Kelley CM; Perez SE; Overk CR; Wynick D; Mufson EJ J Alzheimers Dis; 2011; 25(3):491-504. PubMed ID: 21471639 [TBL] [Abstract][Full Text] [Related]
10. Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42). Rockenstein E; Mallory M; Mante M; Sisk A; Masliaha E J Neurosci Res; 2001 Nov; 66(4):573-82. PubMed ID: 11746377 [TBL] [Abstract][Full Text] [Related]
11. Beta-amyloid plaques induce neuritic dystrophy of nitric oxide-producing neurons in a transgenic mouse model of Alzheimer's disease. Quinn J; Davis F; Woodward WR; Eckenstein F Exp Neurol; 2001 Apr; 168(2):203-12. PubMed ID: 11259108 [TBL] [Abstract][Full Text] [Related]
12. Amyloid cored plaques in Tg2576 transgenic mice are characterized by giant plaques, slightly activated microglia, and the lack of paired helical filament-typed, dystrophic neurites. Sasaki A; Shoji M; Harigaya Y; Kawarabayashi T; Ikeda M; Naito M; Matsubara E; Abe K; Nakazato Y Virchows Arch; 2002 Oct; 441(4):358-67. PubMed ID: 12404061 [TBL] [Abstract][Full Text] [Related]
13. Exclusive association and simultaneous appearance of congophilic plaques and AT8-positive dystrophic neurites in Tg2576 mice suggest a mechanism of senile plaque formation and progression of neuritic dystrophy in Alzheimer's disease. Noda-Saita K; Terai K; Iwai A; Tsukamoto M; Shitaka Y; Kawabata S; Okada M; Yamaguchi T Acta Neuropathol; 2004 Nov; 108(5):435-42. PubMed ID: 15372280 [TBL] [Abstract][Full Text] [Related]
14. Sequential formation of different layers of dystrophic neurites in Alzheimer's brains. Sharoar MG; Hu X; Ma XM; Zhu X; Yan R Mol Psychiatry; 2019 Sep; 24(9):1369-1382. PubMed ID: 30899091 [TBL] [Abstract][Full Text] [Related]
15. Morphological characterization of Thioflavin-S-positive amyloid plaques in transgenic Alzheimer mice and effect of passive Abeta immunotherapy on their clearance. Bussière T; Bard F; Barbour R; Grajeda H; Guido T; Khan K; Schenk D; Games D; Seubert P; Buttini M Am J Pathol; 2004 Sep; 165(3):987-95. PubMed ID: 15331422 [TBL] [Abstract][Full Text] [Related]
16. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease. Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696 [TBL] [Abstract][Full Text] [Related]
17. Rapid microglial response around amyloid pathology after systemic anti-Abeta antibody administration in PDAPP mice. Koenigsknecht-Talboo J; Meyer-Luehmann M; Parsadanian M; Garcia-Alloza M; Finn MB; Hyman BT; Bacskai BJ; Holtzman DM J Neurosci; 2008 Dec; 28(52):14156-64. PubMed ID: 19109498 [TBL] [Abstract][Full Text] [Related]
18. Accumulation of cellular prion protein within dystrophic neurites of amyloid plaques in the Alzheimer's disease brain. Takahashi RH; Tobiume M; Sato Y; Sata T; Gouras GK; Takahashi H Neuropathology; 2011 Jun; 31(3):208-14. PubMed ID: 21062360 [TBL] [Abstract][Full Text] [Related]
19. Association of apolipoprotein J-positive beta-amyloid plaques with dystrophic neurites in Alzheimer's disease brain. Martin-Rehrmann MD; Hoe HS; Capuani EM; Rebeck GW Neurotox Res; 2005; 7(3):231-42. PubMed ID: 15897157 [TBL] [Abstract][Full Text] [Related]